Stephen L. Huhn
CMO & Sr VP, Clinical Dev., Contineum Therapeutics, Inc.
Companies
- Contineum Therapeutics, Inc.CMO & Sr VP, Clinical Dev. Apr 4, 2024 to Jan 31, 20251
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Contineum Therapeutics, Inc. CTNM12,800 shares2$88.3K at $6.89Aug 13, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 13, 2024Exercised options 12,800 shares at $1.01 of Contineum Therapeutics, Inc.2
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2